Status:
COMPLETED
Novel Cardiac Signal Processing System
Lead Sponsor:
BioSig Technologies, Inc.
Conditions:
Cardiac Arrhythmia
Eligibility:
All Genders
18+ years
Brief Summary
This study is designed to collect parallel intracardiac signal data during pre-defined periods of clinical interest from the PURE EP system and the existing signal recording and mapping systems. The ...
Detailed Description
Cardiac electrophysiologists rely on the display of electrograms when performing electrophysiology (EP) studies and catheter ablations in patients with arrhythmias. To achieve effective outcomes witho...
Eligibility Criteria
Inclusion
- Indication for cardiac ablation treatment
- Signed informed consent
Exclusion
- contraindication to electrophysiology study or ablation
- Enrollment in any other ongoing arrhythmia study protocol
- Active Infection or sepsis
- Pregnancy or lactation
- \< 18 years of age
Key Trial Info
Start Date :
November 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 29 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04112433
Start Date
November 12 2019
End Date
January 29 2022
Last Update
February 11 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
3
St. David's Medical Center
Austin, Texas, United States, 78758